Erfan Bashar
Back to Epilepsy

Epilepsy — Prognosis, Surgery, and Driving

~2 min read
Last medically reviewed:
On this pageTable of contents

Educational scope notice: This is a study note for medical students, not medical advice, diagnosis, or treatment guidance. Clinical management should follow local protocols and current guidelines.

Prognostic courses

Four courses are taught as a teaching schema, not as a cited classification. Spontaneously benign epilepsy, such as benign rolandic epilepsy of childhood, resolves on its own. Pharmacologically responsive epilepsy remits after adequate therapy. Pharmacologically dependent epilepsy, including juvenile myoclonic epilepsy, stays controlled only while treated. Pharmacoresistant epilepsy resists drugs and includes syndromes such as Lennox-Gastaut.

Drug-resistant epilepsy means failure of two adequate, tolerated, appropriately chosen and used schedules to reach sustained seizure freedom. About 20 to 30% of patients are drug-resistant, while 70 to 80% achieve acceptable control.

Surgery

Referral follows failure, not age. NICE refers people with drug-resistant seizures, diagnostically uncertain epilepsy, or intolerable side effects to a tertiary epilepsy service within 4 weeks, explicitly including surgery workup. No age gate applies. Presurgical workup centers on neuropsychology, high-resolution structural MRI, and video scalp EEG, with invasive recording when data disagree. Depth electrodes are one invasive option among others, not the default mapping method.

Yield figures come from selected adult temporal lobe populations. In drug-resistant temporal lobe epilepsy, surgery beat continued medical therapy 58% to 8% for freedom from awareness-impairing seizures, with better quality of life. Temporal resection yields seizure freedom in up to 70%, with meaningful reduction in another fifth.

Driving and safety counselling

Driving intervals are set by the licensing jurisdiction, not by a universal seizure-free year. Students must advise a local check. The safety logic is consistent: uncontrolled seizures bar driving, and driving against medical advice risks insurance cover after a crash. Sleep-only or awareness-sparing seizures may qualify after an observation period under local rules, and provoked seizures from an avoidable cause are treated more leniently.

Safety counselling starts at diagnosis. Mortality in epilepsy runs 1.6 to 3.0 times the general population. Death comes from sudden unexpected death in epilepsy (SUDEP) plus injury plus status epilepticus. SUDEP affects about 0.22 per 1,000 child-years and 1.2 per 1,000 adult-years, with a lifetime estimate of 7 to 12%. The major risk factor is the occurrence and frequency of generalized tonic-clonic seizures. Freedom from these seizures is strongly tied to lower SUDEP risk, so ongoing tonic-clonic seizures demand active therapy review. Modifiable risks include non-adherence, alcohol and drug misuse, uncontrolled seizures, and living or sleeping alone. Risk discussion runs from diagnosis onward.

Evidence anchors

Suggest a correction